Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025Blood

Unraveling the distinct biology of ATLL: Clinical and genetic divergence from other peripheral T-cell lymphomas

View Full Paper
Ask AI
Bookmark
Share

Authors

BVBryan Valcárcel

Discussion

Loading...

Member takes

Overview

Retrospective cohort study identifies unique clinical features and transcriptomic signatures for ATLL, suggesting new biomarker applications.

Key Points

  • Malignant transformation associated with distinct gene expression patterns in adult T-cell leukemia/lymphoma.
  • ZCCHC12 emerged as a potential biomarker in ATLL, particularly after differential expression analysis using RNA sequencing.
  • Differential expression analysis involved isolating T-cell subsets and validating findings with immunohistochemistry techniques.
  • Findings suggest that improving diagnostic accuracy and therapeutic targeting for adult T-cell leukemia/lymphoma is critical.

Cite This Study

Bryan Valcárcel (2025) studied this question.

synapsesocial.com/papers/69362f484fa91c937236d695https://doi.org/10.1182/blood-2025-7076
View Full Paper
Ask AI
Bookmark
Share